NewAmsterdam Pharma Warrant

NAMSW

Valor de mercado US$ 42,6 mi

#	Nome	Posição	Valor negociado	Ações Variação	Variação na participação
1	1 Frazier Life Sciences Management Palo Alto, California	US$ 951 mil	–	–	–
2	2 RA Capital Management Boston, Massachusetts	US$ 633 mil	–	–	–
3	3 EcoR1 Capital San Francisco, California	US$ 617 mil	–	–	–
4	4 Affinity Asset Advisors New York	US$ 260 mil	+US$ 194 mil	+100.000	+270%
5	5 Ensign Peak Advisors Salt Lake City, Utah	US$ 255 mil	–	–	–
6	6 Bain Capital Life Sciences Investors Boston, Massachusetts	US$ 190 mil	–	–	–
7	7 Deerfield Management New York	US$ 176 mil	–	–	–
8	8 Highbridge Capital Management New York	US$ 92,1 mil	–	–	–
9	9 HRT Financial New York	US$ 57 mil	–	–	–
10	10 Westchester Capital Management (New York) Valhalla, New York	US$ 54,6 mil	–	–	–
11	11 Walleye Capital New York	US$ 43 mil	-US$ 18,6 mil	-9.600	-30%
12	12 PEAK6 Investments Chicago, Illinois	US$ 32,3 mil	–	–	–
13	13 Laurion Capital Management New York	US$ 31,7 mil	–	–	–
14	14 Clear Street New York	US$ 25,6 mil	–	–	–
15	15 Walleye Trading New York	US$ 24,9 mil	-US$ 10,5 mil	-5.400	-29%
16	ETH 16 Exos TFP Holdings New York	US$ 23,3 mil	-US$ 19,4 mil	-10.000	-45%
17	17 Vestcor Inc Fredericton, New Brunswick, Canada	US$ 18 mil	–	–	–
18	CG 18 Cutler Group San Francisco, California	US$ 9 mil	–	–	–
19	19 UBS Group Zurich, Switzerland	US$ 72	+US$ 74	+38	Nova
20	20 Wolverine Asset Management Chicago, Illinois	–	-US$ 26 mil	-12.448	Encerrada